Patent · US Active

sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases

US8673581B2 · kind B2 · utility

0Cited by

5References

22Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Andreas M. Zeiher · Glückstadt, DE
Christopher Heeschen · Frankfurt am Main, DE
Stefanie Dimmeler · Frankfurt am Main, DE
Christian Hamm · Bad Homburg vor der Höhe, DE

Key dates

Filing date	Sep 13, 2012
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Sep 13, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/32
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.